Gilead Sciences, Inc. today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the fourth quarter of 2017.
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.52 per share of common stock for the fourth quarter of 2017. The dividend is payable on December 28, 2017, to stockholders of record at the close of business on December 15, 2017. Future dividends will be subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171026005957/en/
Contacts
Investors
Gilead Sciences, Inc.
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792
Source: Gilead Sciences, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20171026005957/en
